edited by Seth P. Lerner, Mark P. Schoenberg, Cora N. Sternberg
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Bajorin 28 Treatment of poor risk patients 320 Maria De Santis and Matthew D. Galsky Part VI: Genomics and the current status of urothelial cancer 29 Molecular events in muscle?]invasive bladder cancer development 329 Jonathan Rosenberg, William Y. Kim, Jaegil Kim, and David J. Kwiatkowski 30 Cancer stem cells and intrinsic subtypes in bladder cancer 342 Keith Syson Chan and David J. McConkey 31 Multi?]targeted agents in the treatment of urothelial carcinoma 353 Noah M. Hahn, Colin P.N. Dinney, and Guru Sonpavde Part VII: Optimizing healthcare delivery 32 Patient navigation and cancer navigator programs 365 Scott M. Gilbert and Michael Porter 33 Impact of health services on compliance and outcomes 375 Heather Honoré Goltz, Marc A. Kowalkowski, G. John Chen, and David M
Text of Note
Efstathiou Part IV: Urinary tract reconstruction 21 Orthotopic neobladder 235 Eila C. Skinner 22 Continent cutaneous diversion 244 Andreas Neisius and Joachim W. Thüroff 23 Non?]continent urinary diversion 258 Michael Rink, Fredrik Liedberg, and Margit Fisch Part V: Treatment of regionally advanced and metastatic bladder cancer 24 Molecular determinants of chemotherapy response 273 Matthew I. Milowsky, Peter H. O'Donnell, Thomas W. Flaig, and Dan Theodorescu 25 Neoadjuvant chemotherapy in the treatment of muscle?]invasive bladder cancer 284 David I. Quinn and Cora N. Sternberg 26 Adjuvant chemotherapy for invasive bladder cancer 295 André P. Fay, Jeffrey J. Leow, and Joaquim Bellmunt 27 Treatment of metastatic bladder cancer 304 Gopa Iyer, Fabio Calabró, and Dean F
Text of Note
List of contributors vii Preface xii Acknowledgments xiii Part I: Diagnosis and treatment of non?]muscle?]invasive bladder cancer 1 Pathology 3 Hikmat Al?]Ahmadie and Donna E. Hansel 2 Risk stratification of high?]grade Ta CIS and T1 urothelial carcinoma of the bladder 18 Tobias Klatte, Fred Witjes, Gary Steinberg, and Shahrokh F. Shariat 3 Utility of urine biomarkers 26 Derya Tilki and Alexandre R. Zlotta 4 Novel endoscopic techniques for the detection of bladder cancer 39 Ayman Soubra, Joseph C. Liao, and Badrinath Konety 5 Transurethral resection of bladder tumors 51 Jen?]Jane Liu and Mark P. Schoenberg 6 Intravesical chemotherapy 64 Levent N. Türkeri, M.Guillaume Wientjes, and Jessie L.S. Au 7 Intravesical immunotherapy 76 Nilay M. Gandhi, Laura A. Bertrand, Donald L. Lamm, and Michael A
Text of Note
O'Donnell 8 HGT1 bladder cancer: Diagnosis and treatment 89 J.M. Gaya, J. Palou, and Edward M. Messing 9 What to do when bacillus Calmette?]Guérin fails 98 Massimiliano Spaliviero, Guido Dalbagni, and Matthew Nielsen Part II: T2-4 10 Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction 111 Robert S. Svatek and Alon Z. Weizer 11 Radical cystectomy: Techniques and outcomes 127 Siamak Daneshmand and Seth P. Lerner 12 Cystectomy in the female patient 144 Ryan Werntz, Georgios Gakis, Theresa Koppie, and Arnulf Stenzl 13 Laparoscopic/robotic radical cystectomy and urinary diversion: Outcomes 156 Kristina Wittig, Kevin Chan, Mark Kawachi, and Timothy G. Wilson 14 Robotic assisted radical cystectomy and urinary diversion: Clinical trials 167 George J.S. Kallingal, Angela B